Q32 BIO INC (QTTB) Stock Income Statement
NASDAQ:QTTB - Nasdaq - US7469641051 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 1.16M | 3.21M | 33.97M | |||
| Operating Expenses | 64.20M | 66.30M | 93.44M | 136.49M | 129.92M | |||
| Research and Development | N/A | 48.14M | 62.00M | 98.35M | 93.09M | |||
| Selling, General, and Administrative Expenses | 18.06M | 18.00M | 31.00M | 38.14M | 36.84M | |||
| Operating Income | -64.20M | -66.30M | -92.44M | -133.28M | -95.95M | |||
| Interest Income/Expense | N/A | 5.00M | 5.58M | 3.23M | 190.00K | |||
| Other Income/Expense | -230.00K | 16.00M | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | -700.00K | -560.00K | 131.25M | N/A | |||
| Income Before Taxes | -59.00M | -46.00M | -87.00M | 1.20M | -95.76M | |||
| Income Tax | N/A | 20.00K | 0.00 | 720.00K | N/A | |||
| Net Income | -60.00M | -48.00M | -113.00M | -5.01M | -95.76M | |||
| EBITDA | -63.71M | -65.81M | -91.86M | -131.99M | -87.60M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.98 | -5.15 | -35.20 | -0.09 | -1.73 | |||
| Non GAAP EPS | -4.94 | -18.99 | -26.78 | -1.90 | -1.69 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | -9775.09% | -156.07% | -281.90% | |||
| Operating Profit Margin | N/A | N/A | -7996.54% | -4152.02% | -282.46% | |||
All data in USD